Can Sacubitril/valsartan Become the Promising Drug to Delay the Progression of Chronic Kidney Disease?

Yang Chen,Lu-Ying Guo,Ling-Fei Zhao,Yan-Hong Ma,Xue-Ling Zhu,Ying Xu,Jiang-Hua Chen
DOI: https://doi.org/10.11909/j.issn.1671-5411.2020.12.002
2020-01-01
Journal of Geriatric Cardiology
Abstract:1Introduction Chronic kidney disease (CKD) often coexists with or is a complicationofcardiovasculardisease.Previousstudies have shown that CKD increases the risk of cardiovascular death and all-cause death and was considered to be a risk equivalent of coronary heart disease. [1,2] Adjusted for confounders,decreasedglomerularfiltrationrate(GFR)and increased albuminuria are both independent risk factors for cardiovascular events. [3,4] The risk for cardiovascular death linearly increases with the decline of GFR in a certain range(<70 mL/min per 1.73 m~2) and the increase of albuminuria without a threshold effect. [3]
What problem does this paper attempt to address?